Cell loss no greater with femtosecond lasers

Article

Penetrating keratoplasty (PK) with a femtosecond laser offers good surgical results and endothelial cell loss numbers similar to those found for PK using standard trephines.

Penetrating keratoplasty (PK) with a femtosecond laser offers good surgical results and endothelial cell loss numbers similar to those found for PK using standard trephines, according to Mike Holzer and co-workers at the International Vision Correction Research Centre, Heidelberg University, Germany.

Eleven eyes of 10 subjects underwent uneventful PK with a femtosecond laser. Endothelial cell counts were taken on the corneal donor buttons prior to surgery and measurements were taken at 12 and 24 months postoperatively using a specular microscope.

Preoperative cell counts ranged between 2,300 and 2,750 cells/mm2. At 24 months postoperatively, all corneal transplants were clear and visual acuity had improved from preoperative levels. The postoperative cell counts ranged between 1,350 and 2,100 cells/mm2, whilst the median cell loss was recorded as 35.9%.

It was concluded that cell loss is similar in patients undergoing PK with a femtosecond laser and in those undergoing treatment using conventional trephines.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.